Large-Scale, Parallel-Track Survey Focused on Women's Health Shows Discrepancies Between Patient Preferences and Healthcare Professional Perceptions of Factors Influencing Contraceptive Use in the United States
ROSWELL, Ga., May 18, 2023 /PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced results of a large-scale, parallel-track national survey of women and healthcare professionals (HCPs) conducted by HealthyWomen, the nation's leading independent nonprofit health resource for women. The survey was designed to assess current knowledge and understanding of birth control usage, affordability and beliefs in the United States at a time when women's healthcare choices are being limited or revoked. The survey identified discrepancies in healthcare professional perceptions of their patients' preferences about birth control and factors that influence selection. The survey also sought to explore possible reasons why, despite increased availability of birth control options for women over the past two decades, 45% of pregnancies in the U.S. remain unplanned.1
- The survey was designed to assess current knowledge and understanding of birth control usage, affordability and beliefs in the United States at a time when women's healthcare choices are being limited or revoked.
- The survey identified discrepancies in healthcare professional perceptions of their patients' preferences about birth control and factors that influence selection.
- The parallel-track survey consisted of more than 5,000 women aged 18-55 (n=5,052) and 506 HCPs (OB/GYNs, NPs/PAs and FPs).
- Survey respondents were recruited through a proprietary market panel and the patient survey was balanced to U.S. census for race and ethnicity.